Addressing Methamphetamine Abuse at the Pharmacy Counter

Shilpa Amara, PharmD
Published Online: Monday, September 16, 2013
Follow Pharmacy_Times:

This activity is supported by an educational grant from Acura Pharmaceuticals Inc.

Addressing Methamphetamine Abuse at the Pharmacy Counter

Shilpa Amara, PharmD
Drug Information Specialist
Barnabas Health
South Plainfield, New Jersey



Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose.

Faculty
Shilpa Amara, PharmD

Pharmacy Times Office of Continuing Professional Education

Planning Staff
Judy V. Lum, MPA, and Steve Lin, PharmD

Pharmacy Times Editorial Staff
Kirk McKay and David Allikas

An anonymous peer reviewer was part of the content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.



Educational Objectives
 
Upon completion of the educational activity, the participant should be able to:
  1. Discuss the origins of methamphetamine abuse and its health and economic toll.
  2. Examine the current status of methamphetamine abuse following implementation of legal restrictions on purchasing of implicated OTC drugs.
  3. Identify further efforts taken to minimize use of OTC drugs for manufacture of methamphetamine.
  4. Identify pharmacy implications associated with use of OTC products in methamphetamine production.
Target audience:   Pharmacists
Type of activity:   Knowledge
Release date:   September 13, 2013
Expiration date:   September 13, 2015
Estimated time to complete activity:   2 hours
Fee:   Free

Click here to view this activity.

Related Articles
Reclassifying hydrocodone will not stop the drug from being filled legitimately and sold illegally.
Supporters of the upcoming rescheduling of hydrocodone combination products believe it will help curb our drug abuse and addiction problem in the United States. I don't think so. This article explains why.
New coalition will focus on research and education to combat the abuse and misuse of stimulant medications on college campuses.
The Drug Enforcement Administration recently announced that all hydrocodone products will have a Cll status effective October 6, 2014.
Latest Issues
$auto_registration$